窺得兒醫藥 QDEL 深 滬
已收盤 02-06 16:00:00 美东时间
29.10
+0.410
+1.43%
華盛通- 最 高29.455
- 今 開28.95
- 成交量 78.82万股
- 最 低 28.38
- 昨 收 28.69
- 總市值 19.77亿
- 52周最高 42.50
- 市盈率 靜 --
- 換手率 1.16%
- 52周最低 19.50
- 委 比 -99.16%
- 總股本 6793.15万
- 歷史最高 306.724
- 量 比 0.88
- 振 幅 3.75%
- 歷史最低 12.35
- 每 手 1
- 風險率 4.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | Corvus制药周内狂飙211.8%，特应性皮炎新药临床试验结果积极；Avino银及金矿周涨超32.8%
Corvus制药周内狂飙211.8%，特应性皮炎新药临床试验结果积极；Avino银及金矿周涨超32.8%，现货白银站上100美元>>
01-24 09:50
Strengthening the blood supply: Awareness, challenges and donor impact
SAN DIEGO, Jan. 22, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released episode 55 of its Science Bytes podcast, featuring Mich...
01-22 20:12
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
UBS Maintains Neutral on QuidelOrtho, Raises Price Target to $35
UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises the price target from $31 to $35.
01-21 22:15
Innovating Diagnostics and What's Next
SAN DIEGO, Dec. 18, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jona...
2025-12-18 22:17
QuidelOrtho To Participate In Upcoming Investor Conferences
SAN DIEGO, Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, announced today that members of its management team ...
2025-11-24 20:00
The Power of Prevention: Detecting Diabetes Before It Strikes
SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 53 of its Science Bytes podcast, featuring Qian...
2025-11-20 22:00
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
2025-11-07 10:14
